These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima JAC, Bluemke DA, DCCT/EDIC Research Group. J Am Coll Cardiol; 2013 Jan 29; 61(4):447-454. PubMed ID: 23265339 [Abstract] [Full Text] [Related]
3. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM, DCCT/EDIC Research Group. Diabetes; 2006 Dec 29; 55(12):3556-65. PubMed ID: 17130504 [Abstract] [Full Text] [Related]
6. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes Care; 1999 Jan 29; 22(1):99-111. PubMed ID: 10333910 [Abstract] [Full Text] [Related]
9. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. Writing Team for the DCCT/EDIC Research Group, Gubitosi-Klug RA, Sun W, Cleary PA, Braffett BH, Aiello LP, Das A, Tamborlane W, Klein R. JAMA Ophthalmol; 2016 Feb 29; 134(2):137-45. PubMed ID: 26584339 [Abstract] [Full Text] [Related]
12. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus. Sousa GR, Pober D, Galderisi A, Lv H, Yu L, Pereira AC, Doria A, Kosiborod M, Lipes MA. Circulation; 2019 Feb 05; 139(6):730-743. PubMed ID: 30586738 [Abstract] [Full Text] [Related]
13. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Fährmann ER, Adkins L, Loader CJ, Han H, Rice KM, Denvir J, Driscoll HK. Diabetes Res Clin Pract; 2015 Feb 05; 107(2):280-9. PubMed ID: 25467622 [Abstract] [Full Text] [Related]
14. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes; 1995 Aug 05; 44(8):968-83. PubMed ID: 7622004 [Abstract] [Full Text] [Related]
16. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group. Diabetes Care; 2014 Aug 05; 37(1):31-8. PubMed ID: 24356595 [Abstract] [Full Text] [Related]
18. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. de Boer IH, DCCT/EDIC Research Group. Diabetes Care; 2014 Aug 05; 37(1):24-30. PubMed ID: 24356594 [Abstract] [Full Text] [Related]
19. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Diabetes Care; 2016 May 05; 39(5):686-93. PubMed ID: 26861924 [Abstract] [Full Text] [Related]